KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CSBR
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Champions Oncology stock upgraded from Sell Candidate to Hold/Accumulate after Friday trading session.
(Updated on Apr 26, 2024)

Hold candidate since Apr 26, 2024 PDF

The Champions Oncology stock price fell by -0.791% on the last day (Friday, 26th Apr 2024) from $5.06 to $5.02. During the last trading day the stock fluctuated 0.199% from a day low at $5.02 to a day high of $5.03. The price has been going up and down for this period, and there has been a 0.4% gain for the last 2 weeks. Volume has increased on the last day by 146 shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 thousand shares were bought and sold for approximately $8.13 thousand.

The stock lies the upper part of a wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $5.11 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -20.01% during the next 3 months and, with a 90% probability hold a price between $3.64 and $4.08 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CSBR Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, April 05, 2024, and so far it has risen 3.29%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Champions Oncology stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $5.05 and $5.15. A break-up above any of these levels will issue buy signals. Champions Oncology gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Champions Oncology stock

Champions Oncology finds support from accumulated volume at $5.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.0100 between high and low, or 0.199%. For the last week the stock has had daily average volatility of 0.509%.

Our recommended stop-loss: $4.79 (-4.61%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 15 days ago.)

Trading Expectations (CSBR) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Champions Oncology to open at $5.02, and during the day (based on 14 day Average True Range), to move between $4.89 and $5.15, which gives a possible trading interval of +/-$0.126 (+/-2.51%) up or down from last closing price. If Champions Oncology takes out the full calculated possible swing range there will be an estimated 5.02% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $5.00 (0.40%) than the resistance at $5.50 (9.56%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Champions Oncology stock A Buy?

Champions Oncology holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: -0.750 Hold/Accumulate Upgraded

Predicted Opening Price for Champions Oncology of Monday, April 29, 2024

Fair opening price April 29, 2024 Current price
$5.02 ( 0.0664%) $5.02

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CSBR

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.03 0.266 %
R2 5.03 0.190 %
R1 5.03 0.142 %
Current price: 5.02
Support S1 5.02 -0.0097 %
S2 5.02 -0.0567 %
S3 5.01 -0.133 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.81 15.74 %
R2 5.70 13.55 %
R1 5.50 9.56 %
Current price 5.02
Support S1 5.00 -0.398%
S2 4.98 -0.797%
S3 4.90 -2.39%

FAQ

What is the symbol for Champions Oncology Stock and on which exchange is it traded?
The symbol for Champions Oncology is CSBR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Champions Oncology Stock?
Champions Oncology holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy Champions Oncology Stock?
Champions Oncology Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Champions Oncology Stock.

What's the current price of Champions Oncology Stock?
As of the end of day on the Apr 26, 2024, the price of an Champions Oncology (CSBR) share was $5.02.

What is the 52-week high and low for Champions Oncology Stock?
The 52-week high for Champions Oncology Stock is $7.32 and the 52-week low is $4.17.

What is the market capitalization of Champions Oncology Stock?
As of the Apr 26, 2024, the market capitalization of Champions Oncology is 68.785M.

When is the next earnings date for Champions Oncology?
The upcoming earnings date for Champions Oncology is Jul 22, 2024.
Click to get the best stock tips daily for free!

About Champions Oncology

Champions Oncology Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides Personalized cancer care based upon the implantation of human tumors in immune... CSBR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT